Ewon Comfortech reports 5.5M Liminatus shares

Ewon Comfortech Co., Ltd. has filed an initial ownership report for Liminatus Pharma, Inc., showing holdings of 5,500,000 shares of common stock.

Accepted by SEC EDGAR 07/06/2026 - 04:57 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Ewon Comfortech Co., Ltd. has filed an initial ownership report for Liminatus Pharma, Inc., showing holdings of 5,500,000 shares of common stock. A footnote explains that 4,373,603 of these shares were transferred from Valetudo Therapeutics LLC, which retains voting power over those shares under a voting agreement.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Ewon Comfortech Co., Ltd.

Role 10% Owner

Type	Security	Shares	Price	Value
Holding	Common Stock, par value $0.0001 per share	--	--	--

Holdings: Common Stock, par value $0.0001 per share — 5,500,000 shares (Direct)

Footnotes (1)

1. F1. Consists of 5,500,000 shares of common stock held of record by Ewon Comfortech Co. Ltd ("Ewon"), which includes 4,373,603 shares transferred from Valetudo Therapeutics LLC ("Valetudo") to Ewon on June 24, 2026, which shares Valetudo retains voting power over pursuant to a voting agreement.

Key Figures

Common shares held: 5,500,000 shares Shares from Valetudo: 4,373,603 shares Ownership status: Ten percent owner +1 more

4 metrics

Common shares held 5,500,000 shares Common Stock, par value $0.0001 per share, held of record by Ewon Comfortech

Shares from Valetudo 4,373,603 shares Transferred from Valetudo Therapeutics LLC to Ewon on June 24, 2026

Ownership status Ten percent owner Reporting person classified as ten percent owner of Liminatus Pharma

Voting power over transferred shares Valetudo retains voting power Valetudo keeps voting power over 4,373,603 transferred shares via voting agreement

Key Terms

ten percent owner, voting agreement, voting power, Common Stock, par value $0.0001 per share

4 terms

ten percent owner financial

"Ewon Comfortech Co., Ltd. is identified as a ten percent owner."

voting agreement regulatory

"Valetudo retains voting power over certain shares pursuant to a voting agreement."

A voting agreement is a legally binding pact in which shareholders promise to cast their votes the same way on certain corporate matters, such as electing directors or approving a merger. It matters to investors because it changes who controls company decisions and makes outcomes more predictable—like a group of neighbors agreeing in advance to vote the same way on a community rule, it can strengthen or limit the influence of other shareholders and affect the company’s future direction.

voting power financial

"Valetudo retains voting power over 4,373,603 shares transferred to Ewon."

Voting power is the ability shareholders have to influence a company's major decisions—like electing the board, approving mergers, or changing corporate rules—based on the voting rights attached to the shares they hold. For investors it matters because greater voting power is like holding more keys to a building: it gives you a stronger say over management choices and the company’s strategy, which can affect future value and risk.

Common Stock, par value $0.0001 per share financial

"Security title is Common Stock, par value $0.0001 per share."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Ewon Comfortech disclose in its Form 3 for LIMN?

Ewon Comfortech reports holding 5,500,000 shares of Liminatus Pharma common stock. This establishes it as a significant shareholder and formally records its ownership stake with regulators for public transparency.

How many Liminatus Pharma (LIMN) shares involve Valetudo Therapeutics?

The filing notes 4,373,603 shares were transferred from Valetudo Therapeutics LLC to Ewon Comfortech. Although Ewon holds them of record, Valetudo retains voting power over these shares under a voting agreement.

Is Ewon Comfortech a ten percent owner of Liminatus Pharma (LIMN)?

Yes. Ewon Comfortech is identified as a ten percent owner of Liminatus Pharma. This status triggers Form 3 reporting requirements and highlights Ewon as a major shareholder with a substantial equity stake in the company.

Does the Form 3 for LIMN show any recent share purchases or sales?

The Form 3 primarily records holdings and does not list explicit buy or sell transactions. It focuses on the 5,500,000 shares owned and explains the transfer and voting arrangement involving Valetudo Therapeutics LLC.

Who has voting power over certain Liminatus Pharma shares reported by Ewon?

For 4,373,603 shares, voting power remains with Valetudo Therapeutics LLC under a voting agreement. Ewon holds these shares of record, but Valetudo directs how they are voted on corporate matters.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Ewon Comfortech Co., Ltd.

(Last) (First) (Middle)

8 CHEOMDAN 1-RO JEONGEUP

(Street)

JEONBUK 56212

(City) (State) (Zip)

KOREA, REPUBLIC OF

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/24/2026

3. Issuer Name and Ticker or Trading Symbol
Liminatus Pharma, Inc. [ LIMN ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, par value $0.0001 per share	5,500,000(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Consists of 5,500,000 shares of common stock held of record by Ewon Comfortech Co. Ltd ("Ewon"), which includes 4,373,603 shares transferred from Valetudo Therapeutics LLC ("Valetudo") to Ewon on June 24, 2026, which shares Valetudo retains voting power over pursuant to a voting agreement.

	/s/ Joo Sung Park	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)